News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
809,936 Results
Type
Article (83840)
Company Profile (425)
Press Release (725652)
Multimedia
Podcasts (186)
Webinars (28)
Section
Business (210403)
Career Advice (3548)
Deals (38023)
Drug Delivery (150)
Drug Development (89153)
Employer Resources (194)
FDA (18010)
Job Trends (16662)
News (368415)
Policy (38226)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3010)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (148)
Alliances (54058)
ALS (181)
Alzheimer's disease (1798)
Antibody-drug conjugate (ADC) (348)
Approvals (18194)
Artificial intelligence (590)
Autoimmune disease (163)
Automation (39)
Bankruptcy (384)
Best Places to Work (12505)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (274)
Bladder cancer (164)
Brain cancer (64)
Breast cancer (667)
Cancer (5067)
Cardiovascular disease (450)
Career advice (3031)
Career pathing (41)
CAR-T (306)
CDC (59)
Celiac Disease (2)
Cell therapy (817)
Cervical cancer (38)
Clinical research (75273)
Collaboration (1838)
Company closure (4)
Compensation (1175)
Complete response letters (73)
COVID-19 (2988)
CRISPR (99)
C-suite (881)
Cystic fibrosis (154)
Data (6330)
Decentralized trials (2)
Denatured (63)
Depression (151)
Diabetes (534)
Diagnostics (7162)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (275)
Drug pricing (225)
Drug shortages (36)
Duchenne muscular dystrophy (241)
Earnings (84630)
Editorial (65)
Employer branding (25)
Employer resources (166)
Events (122066)
Executive appointments (1033)
FDA (21211)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1558)
Gene editing (217)
Generative AI (51)
Gene therapy (667)
GLP-1 (1139)
Government (5367)
Grass and pollen (8)
Guidances (387)
Healthcare (20780)
HIV (61)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (296)
Immuno-oncology (62)
Indications (104)
Infectious disease (3278)
Inflammatory bowel disease (206)
Inflation Reduction Act (16)
Influenza (120)
Intellectual property (251)
Interviews (676)
IPO (17619)
IRA (59)
Job creations (4534)
Job search strategy (2467)
JPM (70)
Kidney cancer (16)
Labor market (88)
Layoffs (659)
Leadership (40)
Legal (9493)
Liver cancer (99)
Longevity (15)
Lung cancer (680)
Lymphoma (382)
Machine learning (44)
Management (65)
Manufacturing (849)
MASH (175)
Medical device (14900)
Medtech (14954)
Mergers & acquisitions (21500)
Metabolic disorders (1412)
Multiple sclerosis (165)
NASH (23)
Neurodegenerative disease (354)
Neuropsychiatric disorders (102)
Neuroscience (3128)
Neurotech (1)
NextGen: Class of 2026 (7470)
Non-profit (5090)
Now hiring (65)
Obesity (689)
Opinion (335)
Ovarian cancer (169)
Pain (216)
Pancreatic cancer (234)
Parkinson's disease (302)
Partnered (39)
Patents (513)
Patient recruitment (493)
Peanut (60)
People (63382)
Pharmaceutical (89)
Pharmacy benefit managers (33)
Phase 1 (23147)
Phase 2 (32711)
Phase 3 (24716)
Pipeline (5235)
Policy (337)
Postmarket research (3439)
Preclinical (10384)
Press Release (72)
Prostate cancer (250)
Psychedelics (57)
Radiopharmaceuticals (297)
Rare diseases (924)
Real estate (6899)
Recruiting (79)
Regulatory (28080)
Reports (56)
Research institute (2719)
Resumes & cover letters (564)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (160)
Series A (261)
Series B (198)
Service/supplier (22)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (47)
Startups (4102)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (101)
The Weekly (121)
Vaccines (1144)
Venture capital (98)
Weight loss (473)
Women's health (92)
Worklife (22)
Date
Today (72)
Last 7 days (643)
Last 30 days (2495)
Last 365 days (32020)
2026 (3037)
2025 (32360)
2024 (37380)
2023 (42304)
2022 (53602)
2021 (58329)
2020 (57264)
2019 (50912)
2018 (38776)
2017 (36331)
2016 (36531)
2015 (42191)
2014 (35700)
2013 (33325)
2012 (33744)
2011 (34048)
2010 (33816)
Location
Africa (1174)
Alabama (90)
Alaska (7)
Arizona (314)
Arkansas (14)
Asia (48471)
Australia (8520)
California (11519)
Canada (3305)
China (1179)
Colorado (484)
Connecticut (501)
Delaware (344)
Europe (112987)
Florida (1706)
Georgia (369)
Hawaii (4)
Idaho (68)
Illinois (940)
India (67)
Indiana (532)
Iowa (23)
Japan (434)
Kansas (132)
Kentucky (41)
Louisiana (29)
Maine (83)
Maryland (1450)
Massachusetts (8443)
Michigan (342)
Minnesota (663)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (28)
Nevada (127)
New Hampshire (85)
New Jersey (3101)
New Mexico (32)
New York (3060)
North Carolina (1591)
North Dakota (10)
Northern California (5577)
Ohio (349)
Oklahoma (23)
Oregon (45)
Pennsylvania (2302)
Puerto Rico (23)
Rhode Island (50)
South America (1546)
South Carolina (67)
South Dakota (1)
Southern California (4472)
Tennessee (175)
Texas (1807)
United States (41429)
Utah (348)
Vermont (1)
Virginia (284)
Washington D.C. (87)
Washington State (962)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
809,936 Results for "st jude children s research hospital".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
St. Jude Children’s Research Hospital and ALSAC Announce New Board Members
November 20, 2025
·
6 min read
Press Releases
Children’s Hospital of Philadelphia and St. Jude Researchers Find Genetic Ancestry Influences How Gene Mutations Impact Cancer Prognosis in Patients With T-cell Acute Lymphoblastic Leukemia
June 24, 2025
·
6 min read
Press Releases
Children’s Hospital Los Angeles Researchers Discover Possible Cell of Origin for Ewing Sarcoma
October 13, 2025
·
5 min read
Drug Development
BioLineRx Announces Clinical Trial Agreement with St. Jude Children’s Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)
BioLineRx Ltd. today announced a multi-center Phase 1 clinical trial sponsored by St. Jude Children’s Research Hospital, Inc. to evaluate motixafortide for the mobilization of CD34+ hematopoietic stem cells (HSCs) used in the development of gene therapies for patients with sickle cell disease (SCD).
May 30, 2024
·
8 min read
Press Releases
Inocras, Samsung Medical Center and Seoul St. Mary’s Hospital Researchers Publish Groundbreaking Study with 1,364 Whole-Genomes of Breast Cancer in Nature
December 4, 2025
·
3 min read
Press Releases
Children’s Hospital of Philadelphia Researchers Identify Distinct Pro-Inflammatory Epithelial Cell State in Crohn’s Disease Patients
October 22, 2025
·
5 min read
Press Releases
Children’s Hospital of Philadelphia and Children’s Hospital Colorado Researchers Conduct First Prospective Study of Pediatric EoE Patients and Disease Progression
August 18, 2025
·
5 min read
Press Releases
Children’s Hospital of Philadelphia Pediatric Cancer Researcher Receives Prestigious Grant for Advancing Rare Tumor Studies
September 30, 2025
·
4 min read
Press Releases
Nicklaus Children’s Hospital Joins Children’s Brain Tumor Network to Advance Pediatric Brain Tumor Research
September 26, 2025
·
2 min read
Drug Development
CalciMedica Collaborator St. Jude Children’s Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition
CalciMedica Inc. today announced that its collaborator, St. Jude Children’s Research Hospital (SJCRH), presented data from the initial cohort of the Phase 1/2 CRSPA study of Auxora™ (zegocractin injectable emulsion) in asparaginase-induced pancreatic toxicity (AIPT).
December 11, 2023
·
9 min read
1 of 80,994
Next
